BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33012302)

  • 1. Overlap of lymphatic dysplasia in Fontan-associated protein-losing enteropathy and Mucosa-Associated Lymphoid Tissue (MALT lymphoma): implications for management of protein-losing enteropathy.
    Meisner JK; Koblick S; Walling EB; Rabah R; Schumacher KR
    Cardiol Young; 2020 Dec; 30(12):1973-1975. PubMed ID: 33012302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance Liver Lymphangiography for Investigation and Transhepatic Lymphatic Embolization for the Treatment of Protein-Losing Enteropathy.
    Zaltsberg GS; Lam CZ; Ling SC; Dipchand AI; Chavhan GB; Greer MC; Temple M; Amaral JG
    J Vasc Interv Radiol; 2021 Feb; 32(2):327-329.e2. PubMed ID: 33268048
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein-Losing Enteropathy and Plastic Bronchitis After the Fontan Operation.
    Peyton C
    Crit Care Nurse; 2018 Dec; 38(6):e5-e12. PubMed ID: 30504504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous embolization of lymphatic fistulae as treatment for protein-losing enteropathy and plastic bronchitis in patients with failing Fontan circulation.
    Maleux G; Storme E; Cools B; Heying R; Boshoff D; Louw JJ; Frerich S; Malekzadeh-Milanii S; Hubrechts J; Brown SC; Gewillig M
    Catheter Cardiovasc Interv; 2019 Dec; 94(7):996-1002. PubMed ID: 31596530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new surgical strategy for medically uncontrolled protein-losing enteropathy after Fontan surgery.
    Cha SG; Kim GB; Noh CI; Kim WH
    Interact Cardiovasc Thorac Surg; 2018 Oct; 27(4):629-631. PubMed ID: 29672726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies for protein-losing enteropathy in Fontan-palliated patients.
    Schleiger A; Ovroutski S; Peters B; Schubert S; Photiadis J; Berger F; Kramer P
    Cardiol Young; 2020 May; 30(5):698-709. PubMed ID: 32364090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are children with protein-losing enteropathy after the Fontan operation at increased risk of cytomegalovirus enteropathy? A report of two cases.
    Bauer C; Tulzer G
    Cardiol Young; 2020 Mar; 30(3):431-432. PubMed ID: 31973780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal haemorrhage due to lymphangiectasia caused by protein-losing enteropathy in the Fontan circulation.
    Gras P; Gottrand F; Godart F
    Cardiol Young; 2017 Oct; 27(8):1641-1643. PubMed ID: 28651669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-losing enteropathy after Fontan operation.
    Rychik J
    Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report.
    Kogawa K; Ando T; Fujiwara M
    Cardiol Young; 2021 Aug; 31(8):1333-1335. PubMed ID: 33588957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group.
    Mertens L; Hagler DJ; Sauer U; Somerville J; Gewillig M
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1063-73. PubMed ID: 9605076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure.
    Yetman AT; Everitt MD
    Congenit Heart Dis; 2011; 6(4):370-3. PubMed ID: 21392262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-losing enteropathy after the Fontan operation.
    Feldt RH; Driscoll DJ; Offord KP; Cha RH; Perrault J; Schaff HV; Puga FJ; Danielson GK
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):672-80. PubMed ID: 8800155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation.
    Kim SJ; Park IS; Song JY; Lee JY; Shim WS
    Ann Thorac Surg; 2004 Apr; 77(4):1456-7. PubMed ID: 15063295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of caval venous manipulation in treatment of protein-losing enteropathy.
    Menon S; Hagler D; Cetta F; Gloviczki P; Driscoll D
    Cardiol Young; 2008 Jun; 18(3):275-81. PubMed ID: 18325142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal bleeding and protein-losing enteropathy after the fontan operation.
    Vyas H; Driscoll DJ; Cetta F; Loftus CG; Connolly HM
    Am J Cardiol; 2006 Sep; 98(5):666-7. PubMed ID: 16923458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-losing enteropathy secondary to Fontan procedure resolved after cardiac transplantation.
    Sierra C; Calleja F; Picazo B; Martinez-Valverde A
    J Pediatr Gastroenterol Nutr; 1997 Feb; 24(2):229-30. PubMed ID: 9106114
    [No Abstract]   [Full Text] [Related]  

  • 18. MALT lymphoma of the small bowel with protein-losing enteropathy.
    Tsukamoto A; Nakamura F; Nannya Y; Kobayashi Y; Shibahara J; Ichikawa M; Fukayama M; Koike K; Kurokawa M
    Int J Hematol; 2014 Feb; 99(2):198-201. PubMed ID: 24395281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-losing enteropathy and the Fontan operation.
    Johnson JN; Driscoll DJ; O'Leary PW
    Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Subclinical Enteric Alpha-1-Antitrypsin Loss in Children with Univentricular Circulation Following Total Cavopulmonary Connection.
    Breatnach CR; Cleary A; Prendiville T; Crumlish K; Murchan H; McMahon CJ
    Pediatr Cardiol; 2018 Jan; 39(1):33-37. PubMed ID: 28879464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.